Prevalence of low abundant drug-resistant variants by ultra-deep sequencing in chronically HIV-infected antiretroviral (ARV)-naive patients and the impact on virological outcomes

被引：0
|
作者：
Simen, B. B.
Hullsiek, K. Huppler [1 ]
Novak, R. M. [2 ]
MacArthur, R. D. [3 ]
Baxter, J. D. [4 ]
Huang, C.
Lubeski, C.
Turenchalk, G. S.
Braverman, M. S.
Desany, B.
Simons, J. F.
Rothberg, J. M.
Egholm, M.
Kozal, M. J. [5 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Univ Illinois, Chicago, IL USA
[3] Wayne State Univ, Detroit, MI USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cooper Univ Hosp, Camden, NJ 08103 USA
[5] Yale Univ, Sch Med, New Haven, CT USA
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [1] Prevalence of low abundant drug-resistant variants by ultra-deep sequencing in chronically HIV-infected antiretroviral (ARV)-naive patients and the impact on virological outcomes
    Simen, B. B.
    Hullsiek, K. Huppler
    Novak, R. M.
    MacArthur, R. D.
    Baxter, J. D.
    Huang, C.
    Lubeski, C.
    Turenchalk, G. S.
    Braverman, M. S.
    Desany, B.
    Simons, J. F.
    Rothberg, J. M.
    Egholm, M.
    Kozal, M. J.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S149 - S149
  • [2] Prevalence and clinical significance of transmitted drug-resistant (TDR) HIV mutations by ultra-deep sequencing (UDS) in HIV-infected ARV-naive subjects in CASTLE Study
    Lataillade, M.
    Chiarella, J.
    Yang, R.
    Schnittman, S.
    Wirtz, V.
    Mancini, M.
    Uy, J.
    Seekins, D.
    Krystal, M.
    McGrath, D.
    Simen, B.
    Egholm, M.
    Kozal, M.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A44 - A44
  • [3] Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment-Naive Patients Significantly Impact Treatment Outcomes
    Simen, Birgitte B.
    Simons, Jan Fredrik
    Hullsiek, Katherine Huppler
    Novak, Richard M.
    MacArthur, Rodger D.
    Baxter, John D.
    Huang, Chunli
    Lubeski, Christine
    Turenchalk, Gregory S.
    Braverman, Michael S.
    Desany, Brian
    Rothberg, Jonathan M.
    Egholm, Michael
    Kozal, Michael J.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (05): : 693 - 701
  • [4] Ultra-deep sequencing of HIV from drug resistant patients
    Simons, JF
    Egholm, M
    Lanza, J
    Turenchalk, G
    Desany, B
    Ronan, M
    Knight, J
    Du, L
    Leamon, J
    Rothberg, JM
    Kozal, M
    ANTIVIRAL THERAPY, 2005, 10 (04) : S157 - S157
  • [5] Ultra-deep sequencing of HIV from drug resistant patients
    Simons, JF
    Egholm, M
    Lanza, J
    Turenchalk, G
    Desany, B
    Ronan, M
    Knight, J
    Du, L
    Leamon, J
    Rothberg, JM
    Kozal, M
    ANTIVIRAL THERAPY, 2005, 10 : S157 - S157
  • [6] Impact of drug-resistant tuberculosis on the survival of HIV-infected patients
    Sungkanuparph, S.
    Eampokalap, B.
    Chottanapund, S.
    Thongyen, S.
    Manosuthi, W.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2007, 11 (03) : 325 - 330
  • [7] Prevalence of drug-resistant and nonsubtype BHIV strains in antiretroviral-naive, HIV-Infected individuals in New York state
    Parker, Monica M.
    Gordon, Daniel
    Reilly, Andrew
    Horowitz, Harold W.
    Waters, Mark
    Bennett, Ryan
    Hallack, Renee
    Smith, Joseph
    Lamson, Daryl
    Aydemir, Aida
    Dvali, Natia
    Agins, Bruce D.
    Drusano, George L.
    Taylor, Jill
    AIDS PATIENT CARE AND STDS, 2007, 21 (09) : 644 - 652
  • [8] Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naive Subjects in the CASTLE Study
    Lataillade, Max
    Chiarella, Jennifer
    Yang, Rong
    Schnittman, Steven
    Wirtz, Victoria
    Uy, Jonathan
    Seekins, Daniel
    Krystal, Mark
    Mancini, Marco
    McGrath, Donnie
    Simen, Birgitte
    Egholm, Michael
    Kozal, Michael
    PLOS ONE, 2010, 5 (06):
  • [9] Differences in prevalence of transmitted drug resistance mutations between acutely and chronically HIV-infected, antiretroviral-naive patients
    Yanik, E. L.
    Napravnik, S.
    Hurt, C. B.
    Dennis, A.
    Kuruc, J. D.
    Eron, J. J.
    ANTIVIRAL THERAPY, 2011, 16 : A161 - A161
  • [10] Ultra-deep Sequencing for HIV-1 Minority Drug Resistance Testing Has a Limited Impact on Virological Outcomes
    Su, Bin
    Zheng, Xin
    Liu, Yan
    Liu, Lifeng
    Huang, Chun
    Lu, Hongyan
    Xin, Ruolei
    Liu, Guowu
    Ren, Xianlong
    Mammano, Fabrizio
    Zhang, Tong
    Wu, Hao
    Sun, Lijun
    Dai, Lili
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 133 - 133
12345